Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Colorectal cancer is associated with the presence of cancer driver mutations in normal colon

Julia Matas, Brendan Kohrn, Jeanne Fredrickson, Kelly Carter, Ming Yu, Ting Wang, Xianyong Gui, Thierry Soussi, Victor Moreno, William M. Grady, Miguel A. Peinado, Rosa Ana Risques
doi: https://doi.org/10.1101/2021.10.11.21264780
Julia Matas
1Department of Laboratory Medicine and Pathology, University of Washington, Seattle, USA
2Institut Germans Trias i Pujol, Badalona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brendan Kohrn
1Department of Laboratory Medicine and Pathology, University of Washington, Seattle, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeanne Fredrickson
1Department of Laboratory Medicine and Pathology, University of Washington, Seattle, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelly Carter
3Fred Hutchinson Cancer Research Center, Seattle, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ming Yu
3Fred Hutchinson Cancer Research Center, Seattle, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ting Wang
3Fred Hutchinson Cancer Research Center, Seattle, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xianyong Gui
1Department of Laboratory Medicine and Pathology, University of Washington, Seattle, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thierry Soussi
4Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
5Sorbonne Université, UPMC Univ Paris 06, F- 75005 Paris, France
6INSERM, U1138, Centre de Recherche des Cordeliers, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victor Moreno
7Oncology Data Analytics Program, Catalan Institute of Oncology (ICO), Barcelona, Spain
8Colorectal Cancer Group, ONCOBELL Program, Institut de Recerca Biomedica de Bellvitge (IDIBELL), Barcelona, Spain
9Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Barcelona, Spain
10Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William M. Grady
3Fred Hutchinson Cancer Research Center, Seattle, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miguel A. Peinado
2Institut Germans Trias i Pujol, Badalona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosa Ana Risques
1Department of Laboratory Medicine and Pathology, University of Washington, Seattle, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rrisques@uw.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

While somatic mutations in colorectal cancer (CRC) are well characterized, little is known about the accumulation of cancer mutations in the normal colon prior to cancer. Here we have developed and applied an ultra-sensitive, single-molecule mutational test based on CRISPR-DS technology, which enables mutation detection at extremely low frequency (<0.001) in normal colon from patients with and without CRC. We found oncogenic KRAS mutations in the normal colon of about one third of patients with CRC but in none of the patients without CRC. Patients with CRC also carried more TP53 mutations than patients without cancer, and these mutations were more pathogenic and formed larger clones, especially in patients with early onset CRC. Most mutations in normal colon were different from the driver mutations in tumors suggesting that the occurrence of independent clones with pathogenic KRAS and TP53 mutations is a common event in the colon of individuals that develop CRC.

SIGNIFICANCE Our results suggest a prevalent process of somatic mutation and evolution in the normal colon of patients with CRC, which can be detected by ultra-sensitive sequencing of driver genes and potentially employed clinically for CRC risk prediction.

Competing Interest Statement

RAR is a consultant and equity holder at TwinStrand Biosciences Inc. and an equity holder at NanoString Technologies Inc. RAR is named inventor on patents owned by the University of Washington and licensed to TwinStrand Biosciences Inc. MAP is cofounder and equity holder at Aniling. MAP laboratory has received research funding from Celgene. VM is equity holder of Aniling.

Funding Statement

This work was supported in part by i-PFIs (IFI16/00012) and M-AES (MV19/00042) research fellowships from Instituto de Salud Carlos III to JM; Agencia Estatal de Investigacion (RTI2018-094009-B-100) to MAP; startup funds from the Department of Laboratory Medicine and Pathology to RAR; R50CA233042 to MY; P01CA077852, P30CA042014, P30CA15704, R01189184, R01CA194663, R01CA207371, R01CA220004, U01CA206110, U54CA143862, Listwin Family Foundation, Cottrell Family Fund, R.A.C.E. Charities, Seattle Translational Tumor Research, Rodger C. Haggitt Endowed Chair, and W.H. Geiger Family Foundation to WMG; and Agency for Management of University and Research Grants (AGAUR) of the Catalan Government grant 2017SGR723 to VM.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was conducted following protocols approved by Institutional Review Board committees at the University of Washington and the Fred Hutchinson Cancer Research Center.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 14, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Colorectal cancer is associated with the presence of cancer driver mutations in normal colon
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Colorectal cancer is associated with the presence of cancer driver mutations in normal colon
Julia Matas, Brendan Kohrn, Jeanne Fredrickson, Kelly Carter, Ming Yu, Ting Wang, Xianyong Gui, Thierry Soussi, Victor Moreno, William M. Grady, Miguel A. Peinado, Rosa Ana Risques
medRxiv 2021.10.11.21264780; doi: https://doi.org/10.1101/2021.10.11.21264780
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Colorectal cancer is associated with the presence of cancer driver mutations in normal colon
Julia Matas, Brendan Kohrn, Jeanne Fredrickson, Kelly Carter, Ming Yu, Ting Wang, Xianyong Gui, Thierry Soussi, Victor Moreno, William M. Grady, Miguel A. Peinado, Rosa Ana Risques
medRxiv 2021.10.11.21264780; doi: https://doi.org/10.1101/2021.10.11.21264780

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (559)
  • Anesthesia (135)
  • Cardiovascular Medicine (1779)
  • Dentistry and Oral Medicine (240)
  • Dermatology (173)
  • Emergency Medicine (317)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10840)
  • Forensic Medicine (8)
  • Gastroenterology (595)
  • Genetic and Genomic Medicine (2970)
  • Geriatric Medicine (289)
  • Health Economics (534)
  • Health Informatics (1938)
  • Health Policy (837)
  • Health Systems and Quality Improvement (747)
  • Hematology (296)
  • HIV/AIDS (634)
  • Infectious Diseases (except HIV/AIDS) (12536)
  • Intensive Care and Critical Care Medicine (697)
  • Medical Education (300)
  • Medical Ethics (89)
  • Nephrology (325)
  • Neurology (2822)
  • Nursing (152)
  • Nutrition (436)
  • Obstetrics and Gynecology (561)
  • Occupational and Environmental Health (600)
  • Oncology (1476)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (259)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (382)
  • Pediatrics (870)
  • Pharmacology and Therapeutics (368)
  • Primary Care Research (341)
  • Psychiatry and Clinical Psychology (2654)
  • Public and Global Health (5394)
  • Radiology and Imaging (1019)
  • Rehabilitation Medicine and Physical Therapy (599)
  • Respiratory Medicine (729)
  • Rheumatology (330)
  • Sexual and Reproductive Health (294)
  • Sports Medicine (280)
  • Surgery (330)
  • Toxicology (48)
  • Transplantation (151)
  • Urology (127)